SCHEMBL8749237

SCHEMBL8749237

COc1ccc2ccc(I)cc2c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 2/20 0.61
CYP1A2 P05177 1/20 0.61
RAB9A P51151 2/20 0.52
HSD17B1 P14061 1/20 0.48
HSD17B2 P37059 1/20 0.48
APP P05067 5/20 0.47
KDM4E B2RXH2 1/20 0.46
GSTP1 P09211 1/20 0.46
HTR1A P08908 1/20 0.45
HTR1D P28221 1/20 0.45
HTR1B P28222 1/20 0.45
CYP17A1 P05093 1/20 0.45
CYP11B2 P19099 1/20 0.45
NCF1 P14598 1/20 0.44
MEN1 O00255 1/20 0.42
POLB P06746 1/20 0.42
MAPK1 P28482 1/20 0.42
KMT2A Q03164 1/20 0.42
NQO1 P15559 1/20 0.42
PTGS1 P23219 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2217612 0.96 CYP2A6 (0.60) CYP2A6CYP1A2RAB9AHSD17B1HSD17B2
SCHEMBL443528 0.86 CYP2A6 (0.80) CYP2A6CYP1A2RAB9AHSD17B1HSD17B2
SCHEMBL29367032 0.86 CYP2A6 (0.80) CYP2A6CYP1A2RAB9AHSD17B1HSD17B2
SCHEMBL7452675 0.81 CYP1A2 (0.71) CYP2A6CYP1A2RAB9AHSD17B1HSD17B2
SCHEMBL7456084 0.81 CYP1A2 (0.71) CYP2A6CYP1A2RAB9AHSD17B1HSD17B2
SCHEMBL29919511 0.81 CYP1A2 (0.71) CYP2A6CYP1A2RAB9AHSD17B1HSD17B2
SCHEMBL7451812 0.81 CYP1A2 (0.71) CYP2A6CYP1A2RAB9AHSD17B1HSD17B2
SCHEMBL6891918 0.81 CYP1A2 (0.71) CYP2A6CYP1A2RAB9AHSD17B1HSD17B2
SCHEMBL2249185 0.81 CYP1A2 (0.71) CYP2A6CYP1A2RAB9AHSD17B1HSD17B2
SCHEMBL443070 0.81 CYP1A2 (0.79) CYP2A6CYP1A2RAB9AHSD17B1HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0416038-A4 NOVEL CHEMILUMINESCENT FUSED POLYCYCLIC RING-CONTAINING 1,2-DIOXETANES AND ASSAYS IN WHICH THEY ARE USED 1992-02-26 EP claimed
EP-0416038-A1 NOVEL CHEMILUMINESCENT FUSED POLYCYCLIC RING-CONTAINING 1,2-DIOXETANES AND ASSAYS IN WHICH THEY ARE USED. TROPIX INC (US) 1991-03-13 EP claimed
WO-1990000164-A1 NOVEL CHEMILUMINESCENT FUSED POLYCYCLIC RING-CONTAINING 1,2-DIOXETANES AND ASSAYS IN WHICH THEY ARE USED TROPIX, INC. (US) 1990-01-11 WO claimed
US-20260035339-A1 TETRAHYDRONAPHTHALENE DERIVATIVE ATRANSEN PHARMA LTD (JP) 2026-02-05 US disclosed
EP-4501906-A1 TETRAHYDRONAPHTHALENE DERIVATIVE Atransen Pharma Ltd. (JP) 2025-02-05 EP disclosed
CN-118974007-A Tetrahydronaphthalene derivatives 阿创森制药股份有限公司 2024-11-15 CN disclosed
WO-2023190878-A1 TETRAHYDRONAPHTHALENE DERIVATIVE Atransen Pharma株式会社 2023-10-05 WO disclosed
EP-0416038-B1 NOVEL CHEMILUMINESCENT FUSED POLYCYCLIC RING-CONTAINING 1,2-DIOXETANES AND ASSAYS IN WHICH THEY ARE USED TROPIX INC (US) 1997-03-26 EP disclosed
EP-0416038-A4 NOVEL CHEMILUMINESCENT FUSED POLYCYCLIC RING-CONTAINING 1,2-DIOXETANES AND ASSAYS IN WHICH THEY ARE USED 1992-02-26 EP disclosed
EP-0416038-A1 NOVEL CHEMILUMINESCENT FUSED POLYCYCLIC RING-CONTAINING 1,2-DIOXETANES AND ASSAYS IN WHICH THEY ARE USED. TROPIX INC (US) 1991-03-13 EP disclosed
US-4952707-A DECOMPOSITION TO LIGHT EMITTING FLUOROPHORE; ANALYSIS TROPIX, INC. (US) 1990-08-28 US disclosed
WO-1990000164-A1 NOVEL CHEMILUMINESCENT FUSED POLYCYCLIC RING-CONTAINING 1,2-DIOXETANES AND ASSAYS IN WHICH THEY ARE USED TROPIX, INC. (US) 1990-01-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260035339-A1 TETRAHYDRONAPHTHALENE DERIVATIVE LATS1, LATS2, BCAT1 CYP2A6 1376/4885CYP1A2 2904/4885RAB9A 516/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.